文献速递免疫规划职业卫生

缩短为一周皮内狂犬病暴露前预防在医护人员中的免疫原性及其加强能力:一项回顾性观察性队列研究

Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study.
PubMed 文献 · Vaccine · 2025-09-27

该回顾性疫苗接种记录审查评估了医护人员按机构生物安全方案接种一周、两部位皮内狂犬病暴露前预防方案的免疫原性,并评估1-3年后加强针的免疫应答。92名医护人员第14天平均狂犬病毒中和抗体滴度达13.40 IU/mL,39名医护人员加强后平均滴度达51.13 IU/mL,表明该缩短方案在高危职业环境中具有免疫原性和长期加强能力。

要点

  • 92名医护人员接种一周两部位皮内暴露前预防方案后第14天均达到足够血清阳转(RVNA≥0.5 IU/mL),平均滴度13.40 IU/mL。
  • 39名医护人员在1-3年后接种加强针,加强前平均滴度2.76 IU/mL,加强后平均滴度51.13 IU/mL,显示强回忆应答。
  • 该缩短方案在所有医护人员中引发稳健血清阳转和强二次免疫应答,支持其在高危职业环境中的免疫原性和长期加强能力。

核心结论

  • 该一周两部位皮内暴露前预防方案在所有医护人员中引发稳健血清阳转,并诱导强二次免疫应答,支持该缩短方案在高危职业环境中的免疫原性和长期加强能力。

研究设计与样本

  • 回顾性疫苗接种记录审查,评估医护人员按机构生物安全方案接种一周、两部位皮内狂犬病暴露前预防方案后的免疫原性及1-3年后加强针的免疫应答。

主要发现

  • 92名医护人员基线平均狂犬病毒中和抗体滴度为0.13 IU/mL,第14天达到足够血清阳转(RVNA≥0.5 IU/mL),平均滴度13.40 IU/mL。
  • 39名医护人员加强前平均滴度为2.76 IU/mL,1-3年后接种加强针,加强后平均滴度51.13 IU/mL,表明强回忆应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rabies pre-exposure prophylaxis (PrEP) is recommended for those at high occupational risk, including health care workers (HCWs) in rabies-endemic settings. Following institutional biosafety protocols, HCWs receive a one-week, two-site intradermal (ID) PrEP regimen. This retrospective vaccination records review assessed the immunogenicity of this regimen following primary vaccination and evaluated the immune response to a booster dose administered 1-3 years later. 92 HCWs with mean baseline rabies virus neutralizing antibody (RVNA) titres of 0.13 IU/mL showed adequate seroconversion (RVNA ≥ 0.5 IU/mL) by day 14, with mean titre of 13.40 IU/mL. 39 HCWs with mean pre-booster titre of 2.76 IU/mL received a booster 1-3 years later and mean post-booster titres were 51.13 IU/mL, indicating a strong anamnestic response. The regimen elicited robust seroconversion in all HCWs and induced a strong secondary immune response, supporting the immunogenicity and long-term boostability of this shortened regimen in high-risk occupational settings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ashwini MA, Gupta S, Lodha L, et al. Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study. Vaccine. 2025. PMID: 41016232. doi:10.1016/j.vaccine.2025.127787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。